COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1282: Articles 12811-12820  | Next

Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
Abe, K. T., Hu, Q., Mozafarihashjin, M., Samson, R., Manguiat, K., Robinson, A., Rathod, B., Chao, G., Wang, J. H., Iskilova, M., Pasculescu, A., Fazel-Zarandi, M., Li, A., Paterson, A., Green, K., Gilbert, L., Barati, S., Haq, N., Takaoka, A., Garnham Takaoka, J., Quinn De Launay, K., Fahim, C., Sheikh-Mohamed, S., Arita, Y., Durocher, Y., Marcusson, E. G., Gommerman, J. L., Ostrowski, M., Colwill, K., Straus, S. E., Wood, H., McGeer, A. J., Gingras, A.-C.
10.1101/2021.08.06.21261721 — Posted: 2021-08-08
Modelling the effectiveness and social costs of daily lateral flow antigen tests versus quarantine in preventing onward transmission of COVID-19 from traced contacts
Ferretti, L., Wymant, C., Nurtay, A., Zhao, L., Hinch, R., Bonsall, D., Kendall, M., Masel, J., Bell, J., Hopkins, S., Kilpatrick, A. M., Peto, T., Abeler-Dörner, L., Fraser, C.
10.1101/2021.08.06.21261725 — Posted: 2021-08-08 Discussion: Offsite
Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough cases.
Mutnal, M. B., Johnson, S., Mohamed, N., Abddelgader, R., Morales, L., Volz, M., Walker, K., Arroliga, A. C., Rao, A.
10.1101/2021.08.06.21261727 — Posted: 2021-08-08
HIF1alpha cardioprotection in COVID-19 patients
Wang, B. J., Vadakke-Madathil, S., Croft, L. B., Brody, R. I., Chaudhry, H. W.
10.1101/2021.08.05.21258160 — Posted: 2021-08-07
Estimation of Total Immunity to SARS-CoV-2 in Texas
Desantis, S. M., Leon-Novelo, L. G., Swartz, M. D., Yaseen, A., Valerio-Shewmaker, M. A., Brito, F. A., Ross, J. A., Kohl, H. W., Messiah, S. M., Kelder, S. H., Wu, L., Zhang, S., Aguillard, K. A., Gonzalez, M. O., OmegaNjemnobi, O. S., Lakey, D., Shuford, J., Pont, S., Boerwinkle, E.
10.1101/2021.08.05.21261610 — Posted: 2021-08-07 Discussion: Onsite
Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine
Nomura, Y., Sawahata, M., Nakamura, Y., Kurihara, M., Koike, R., Katsube, O., Hagiwara, K., Niho, S., Masuda, N., Tanaka, T., Sugiyama, K.
10.1101/2021.08.06.21261590 — Posted: 2021-08-07
Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region
Strathdee, S. A., Abramovitz, D., Harvey-Vera, A., Vera, C., Rangel, G., Artamonova, I., Chaillon, A., Ignacio, C., Calderon, A., Martin, N. K., Patterson, T. L.
10.1101/2021.08.05.21261671 — Posted: 2021-08-07
Determinants of the COVID-19 Vaccine Hesitancy Spectrum
Piltch-Loeb, R., Silver, D., Kim, Y., Norris, H., McNeill, E., Abramson, D.
10.1101/2021.08.05.21261675 — Posted: 2021-08-07
Trends in accident-related admissions to pediatric intensive care units during the first COVID-19 lockdown in Germany
Bruns, N., Willemsen, L. Y., Holtkamp, K., Kamp, O., Dudda, M., Kowall, B., Stang, A., Hey, F., Blankenburg, J., Sabir, H., Eifinger, F., Fuchs, H., Haase, R., Andree, C., Heldmann, M., Potratz, J., Kurz, D., Schumann, A., Mueller-Knapp, M., Mand, N., Doerfel, C., Dahlem, P., Rothoeft, T., Ohlert, M., Silkenbaeumer, K., Dohle, F., Indraswari, F., Niemann, F., Jahn, P., Merker, M., Braun, N., Brevis Nunez, F., Engler, M., Heimann, K., Wolf, G., Wulf, D., Holborn, C., Freymann, H., Allgaier, N., Knirsch, F., Dercks, M., Reinhard, J., Hoppenz, M., Felderhoff-Mueser, U., Dohna-Schwake, C.
10.1101/2021.08.06.21261728 — Posted: 2021-08-07
Preterm birth rates during the COVID-19 lockdown in Queensland Australia
Jasper, B., Stillerova, T., Anstey, C., Weaver, E.
10.1101/2021.08.06.21261711 — Posted: 2021-08-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).